Back
Day Range
$13.12
$14.19
52-Week Range
$7.98
$19.51
Volume
291,900
50D / 200D Avg
$15.62
/
$14.17
Prev Close
$13.97
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -17.0 | 0.4 |
| P/B | 2.9 | 2.9 |
| ROE % | -21.0 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -43.67M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-21.04%
ROIC-16.24%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio34.13
Interest Coverage-131.05
Valuation
P/E Ratio
-16.98
P/B Ratio2.93
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -48.26M |
| ROE | -21.04% | ROA | -16.74% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -43.67M |
| ROIC | -16.24% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 34.13 |
| Interest Coverage | -131.05 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -16.98 | P/B Ratio | 2.93 |
| P/S Ratio | N/A | PEG Ratio | -3.01 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 819.41M | Enterprise Value | 573.67M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -48.26M | -38.96M | -35.59M | -22.46M | -9.20M |
| EPS (Diluted) | -0.79 | -0.75 | -0.68 | -0.14 | -0.18 |
| Gross Profit | -335,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -60.68M | -50.31M | -41.22M | -30.55M | -15.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 288.23M | 188.27M | 226.30M | 254.36M | 279.92M |
| Total Liabilities | 8.53M | 9.32M | 7.33M | 4.55M | 2.75M |
| Shareholders' Equity | 279.70M | 178.95M | 218.97M | 249.82M | 277.18M |
| Total Debt | 512,000.0 | 624,000.0 | 974,000.0 | 0.0 | 0.0 |
| Cash & Equivalents | 246.25M | 100.79M | 78.42M | 165.96M | 276.78M |
| Current Assets | 285.98M | 154.23M | 164.09M | 168.54M | 279.84M |
| Current Liabilities | 8.38M | 8.95M | 6.70M | 4.55M | 2.75M |